The receptor tyrosine kinase ROR1 – An oncofetal antigen for targeted cancer therapyMohammad Hojjat‐Farsangi, Håkan Mellstedt, Abdul Salam Khan et al.|Seminars in Cancer Biology|2014Cited by 99
The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodiesAmir Hossein Daneshmanesh, Håkan Mellstedt, Mohammad Hojjat‐Farsangi et al.|British Journal of Haematology|2014Cited by 39
Abstract 4770: Anti-ROR1 monoclonal antibodies induce apoptosis in pancreatic cancer cells via the PI3-kinase/AKT/mTOR pathwayAmir Hossein Daneshmanesh, Håkan Mellstedt, Mohammad Hojjat‐Farsangi et al.|Cancer Research|2014Cited by 7
A new class of compound for pancreatic carcinoma targeting the tyrosine kinase receptor (TKR) ROR1.Håkan Mellstedt, Anders Österborg, Thomas Olin et al.|Journal of Clinical Oncology|2014Cited by 5